Page 1 | Search Results | Blood | American Society of Hematology

1-18 of 18

Sort by

Sort Order Select

Journal Articles

Real-Life Efficacy and Safety of Vemurafenib Plus Rituximab (V+R) in Relapsed or Refractory Hairy Cell Leukemia: A Multi-Center Retrospective Study (HCL-PG03R)

Blood (2023) 142 (Supplement 1): 3027.

https://doi.org/10.1182/blood-2023-178648

Published: 2023

Journal Articles

Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) and Lymphocyte to Monocyte Ratio (LMR) in Newly Diagnosed Advanced-Stage Hodgkin Lymphoma Patients Treated up-Front with a PET-2 Risk Adapted Protocol

Blood (2018) 132 (Supplement 1): 2934.

https://doi.org/10.1182/blood-2018-99-115346

Published: 2018

Journal Articles

Prophylaxis with ATLG Significantly Improves Chronic Graft-Versus-Host Disease / Relapse-Free Survival and Quality of Life after a Myeloablative HLA Identical Sibling Transplant for Acute Leukemia Patients in Complete Remission. Long-Term Follow-up of the Randomized ATG Familystudy

Blood (2017) 130 (Supplement 1): 519.

https://doi.org/10.1182/blood.V130.Suppl_1.519.519

Published: 2017

Journal Articles

Early Reduction of Serum TARC Levels Predicts Prognosis of Patients Treated with a PET-Adapted Strategy for Advanced Stage Hodgkin Lymphoma (HL) in the GITIL/FIL HD0607 Trial

Blood (2017) 130 (Supplement 1): 1511.

https://doi.org/10.1182/blood.V130.Suppl_1.1511.1511

Published: 2017

Journal Articles

Prevention of Chronic GvHD after HLA-Identical Sibling Peripheral Hematopietic Stem Cell Transplantation with or without Anti-Lymphocyte Globulin (ATG). Results from a Prospective, Multicenter Randomized Phase III Trial (ATGfamilystudy)

Blood (2014) 124 (21): 37.

https://doi.org/10.1182/blood.V124.21.37.37

Published: 2014

Journal Articles

Efficacy and Safety of the BRAF Inhibitor Vemurafenib in Hairy Cell Leukemia Patients Refractory to or Relapsed after Purine Analogs: A Phase-2 Italian Clinical Trial

Enrico Tiacci, Luca De Carolis, Pier Luigi Zinzani, Alessandro Pulsoni, Francesco Zaja, Michele Cimminiello, Achille Ambrosetti, Davide Rossi, Giovanna Motta, Marzia Varettoni, Vincenzo Fraticelli, Angelo Michele Carella, Antonella Anastasia, Pietro Leoni, Alessandro Rambaldi, Stefano Aldo Pileri, Robin Foà, Brunangelo Falini

Blood (2014) 124 (21): 150.

https://doi.org/10.1182/blood.V124.21.150.150

Published: 2014

Journal Articles

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD

Blood (2013) 122 (25): 4111–4118.

https://doi.org/10.1182/blood-2013-05-494278

Published: 2013

Includes: Supplemental data

Journal Articles

Association Between Immunoparesis and a Skewed Free Light Chain (FLC) Ratio: A New Prognostic Factor Of Progression from MGUS To Multiple Myeloma?

Michele Pizzuti, Alberto Santagostino, Giuseppina Smaldore, Ida Chitarrelli, Domenico Vertone, Sara Pasquina Pascale, Angela Matturro, Immacolata Attolico, Angela Amendola, Michele Cimminiello, Nunzio Filardi, Antonella Girardi, Romina Penitente, Roberta Nuccorini, Sabrina Coluzzi, Enza Scavone

Blood (2013) 122 (21): 5314.

https://doi.org/10.1182/blood.V122.21.5314.5314

Published: 2013

Journal Articles

Evaluation Of Factor V Leiden, Prothrombin Mutations and The Homozygous mutation 677T In The MTHFR Gene In Patients With Venous Thrombosis

Michele Pizzuti, Alberto Santagostino, Maria Antonietta Rizzo, Daniela Dragonetti, Maria Grazia Pietrafesa, Immacolata Attolico, Angela Amendola, Nunzio Filardi, Michele Cimminiello, Angela Matturro, Domenico Vertone, Roberta Nuccorini, sara Pasquina Pascale, Sabrina Coluzzi

Blood (2013) 122 (21): 4798.

https://doi.org/10.1182/blood.V122.21.4798.4798

Published: 2013

Journal Articles

Nilotinib For Steroid-Refractory Chronic Graft Versus Host Disease (SR-cGVHD): Preliminary Results Of a Phase I-II GITMO Study (Gruppo Italiano Trapianto di Midollo Osseo)

Attilio Olivieri, Prof., Michele Cimminiello, MD, PhD, Ivana Latesoriere, Pietro Leoni, Francesco Onida, MD, Roberta Fedele, MD, Paolo Corradini, Vincenzo Pavone, Roberta Nuccorini, Sara Pasquina Pascale, Jacopo Olivieri, Giorgia Mancini, MD, Sonia Mammoliti, Alessandro Rambaldi, MD

Blood (2013) 122 (21): 4608.

https://doi.org/10.1182/blood.V122.21.4608.4608

Published: 2013

Journal Articles

Evaluation of MRD Status by Flow Cytometry and PCR in Multiple Myeloma Elderly Patients Receiving Autologous Stem Cell Transplantation After Bortezomib-Supplemented Mobilization and Conditioning

Immacolata Attolico, Roberta Nuccorini, Alberto Fragasso, Vincenzo Pavone, Pellegrino Musto, Silvana Capalbo, MD, Gaetano Palumbo, MD, Giorgina Specchia, Cristiana Carniti, PhD, Paolo Corradini, MD, Sara Pascale, Sabrina Coluzzi, Michele Pizzuti, Angela Amendola, Michele Cimminiello, Angela Matturro, Domenico Vertone, Nunzio Filardi, Attilio Olivieri, MD

Blood (2012) 120 (21): 4523.

https://doi.org/10.1182/blood.V120.21.4523.4523

Published: 2012

Journal Articles

Imatinib Is Safe and Effective In Patients with Refractory Chronic Graft Versus Host Disease: Analysis of Two Consecutive Prospective GITMO* Studies.*Gruppo Italiano Trapianto Midollo Osseo

Attilio Olivieri, Michele Cimminiello, MD, PhD, Franco Locatelli, MD, FRCPath, Marco Zecca, Paolo Corradini, MD, Francesca Patriarca, Nicola Mordini, Pasquale Iacopino, Amedea Donelli, MD, Carmine Selleri, MD, Manuela Badiali, Giovanna Lucchini, MD, Guido Gini, Pietro Leoni, MD, Alberto Bosi, Andrea Bacigalupo, MD

Blood (2010) 116 (21): 246.

https://doi.org/10.1182/blood.V116.21.246.246

Published: 2010

Journal Articles

Imatinib as Salvage Therapy for Patients with Refractory cGVHD: the Interim Analysis of the Prospective GITMO* Multicenter Study*Gruppo Italiano Trapianto Di Midollo Osseo.

Attilio Olivieri, MD, Michele Cimminiello, Paolo Corradini, MD, Pasquale Iacopino, MD, Amedea Donelli, Nicola Mordini, Carmine Selleri, Vincenzo Pavone, Renato Fanin, Franco Locatelli, Andrea Bacigalupo, MD, Alberto Bosi, MD

Blood (2009) 114 (22): 3558.

https://doi.org/10.1182/blood.V114.22.3558.3558

Published: 2009

Journal Articles

Response: Imatinib in lung cGVHD of mild to moderate severity

Attilio Olivieri, Michele Cimminiello, Franco Locatelli

Blood (2009) 114 (17): 3719–3720.

https://doi.org/10.1182/blood-2009-08-233551

Published: 2009

Journal Articles

Imatinib for refractory chronic graft-versus-host disease with fibrotic features

Attilio Olivieri, Franco Locatelli, Marco Zecca, Adele Sanna, Michele Cimminiello, Roberto Raimondi, Guido Gini, Nicola Mordini, Adriana Balduzzi, Pietro Leoni, Armando Gabrielli, Andrea Bacigalupo

Blood (2009) 114 (3): 709–718.

https://doi.org/10.1182/blood-2009-02-204156

Published: 2009

Includes: Supplemental data

Journal Articles

In Vivo Purging Followed by AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) in PATIENTS with MULTIPLE MYELOMA (MM): Preliminary RESULTS of a Pilot STUDY

Imma Attolico, MD, Domenico Vertone, MD, Nunzio Filardi, MD, Michele Pizzuti, MD, Monica Poggiaspalla, MD, Michele Cimminiello, MD, Sabrina Coluzzi, Attilio Olivieri, MD

Blood (2008) 112 (11): 4458.

https://doi.org/10.1182/blood.V112.11.4458.4458

Published: 2008

Journal Articles

Radioimmunotherapy ( 90 Y-Zevalin®) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study.

Blood (2008) 112 (11): 1144.

https://doi.org/10.1182/blood.V112.11.1144.1144

Published: 2008

Journal Articles

Safety and Tolerability of Intrathecal Liposomal Cytarabine during CNS Prophylaxis in Patients with Non Hodgkin Lymphoma and Acute Lymphoblastic Leukemia.

Luciana Annino, MD, Barbara Anaclerico, MD, Giulia Benevolo, MD, Nicola Cascavilla, MD, Michele Cimminiello, MD, Matteo Dell’Olio, MD, Alfredo Gagliardi, MD, Giulio Giordano, MD, Eustachio Miraglia, MD, Maurizio Musso, MD, Guido Parvis, MD, Silvia Piano, MD, Chiara Pilatrino, MD, Renato Scalone, MD, Adriano Venditti, MD, Daniela Venditti, MD, Umberto Vitolo, MD, Sergio Storti, MD

Blood (2007) 110 (11): 4460.

https://doi.org/10.1182/blood.V110.11.4460.4460

Published: 2007

NARROW

Real-Life Efficacy and Safety of Vemurafenib Plus Rituximab (V+R) in Relapsed or Refractory Hairy Cell Leukemia: A Multi-Center Retrospective Study (HCL-PG03R)

Prognostic Relevance of Neutrophil to Lymphocyte Ratio (NLR) and Lymphocyte to Monocyte Ratio (LMR) in Newly Diagnosed Advanced-Stage Hodgkin Lymphoma Patients Treated up-Front with a PET-2 Risk Adapted Protocol

Prophylaxis with ATLG Significantly Improves Chronic Graft-Versus-Host Disease / Relapse-Free Survival and Quality of Life after a Myeloablative HLA Identical Sibling Transplant for Acute Leukemia Patients in Complete Remission. Long-Term Follow-up of the Randomized ATG Familystudy

Early Reduction of Serum TARC Levels Predicts Prognosis of Patients Treated with a PET-Adapted Strategy for Advanced Stage Hodgkin Lymphoma (HL) in the GITIL/FIL HD0607 Trial

Prevention of Chronic GvHD after HLA-Identical Sibling Peripheral Hematopietic Stem Cell Transplantation with or without Anti-Lymphocyte Globulin (ATG). Results from a Prospective, Multicenter Randomized Phase III Trial (ATGfamilystudy)

Efficacy and Safety of the BRAF Inhibitor Vemurafenib in Hairy Cell Leukemia Patients Refractory to or Relapsed after Purine Analogs: A Phase-2 Italian Clinical Trial

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD

Association Between Immunoparesis and a Skewed Free Light Chain (FLC) Ratio: A New Prognostic Factor Of Progression from MGUS To Multiple Myeloma?

Evaluation Of Factor V Leiden, Prothrombin Mutations and The Homozygous mutation 677T In The MTHFR Gene In Patients With Venous Thrombosis

Nilotinib For Steroid-Refractory Chronic Graft Versus Host Disease (SR-cGVHD): Preliminary Results Of a Phase I-II GITMO Study (Gruppo Italiano Trapianto di Midollo Osseo)

Evaluation of MRD Status by Flow Cytometry and PCR in Multiple Myeloma Elderly Patients Receiving Autologous Stem Cell Transplantation After Bortezomib-Supplemented Mobilization and Conditioning

Imatinib Is Safe and Effective In Patients with Refractory Chronic Graft Versus Host Disease: Analysis of Two Consecutive Prospective GITMO* Studies.*Gruppo Italiano Trapianto Midollo Osseo

Imatinib as Salvage Therapy for Patients with Refractory cGVHD: the Interim Analysis of the Prospective GITMO* Multicenter Study*Gruppo Italiano Trapianto Di Midollo Osseo.

Response: Imatinib in lung cGVHD of mild to moderate severity

Imatinib for refractory chronic graft-versus-host disease with fibrotic features

In Vivo Purging Followed by AUTOLOGOUS STEM CELL TRANSPLANTATION (ASCT) in PATIENTS with MULTIPLE MYELOMA (MM): Preliminary RESULTS of a Pilot STUDY

Radioimmunotherapy ( 90 Y-Zevalin®) Combined with BEAM Conditioning Regimen and Autologous Stem Cell Transplantation for the Treatment of Non Hodgkin Lymphomas: Results of An Italian Multicenter Study.

Safety and Tolerability of Intrathecal Liposomal Cytarabine during CNS Prophylaxis in Patients with Non Hodgkin Lymphoma and Acute Lymphoblastic Leukemia.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only